Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition

被引:57
作者
Leuthäuser, K
Gujer, R
Aldecoa, A
McKinney, RA
Muff, R
Fischer, JA
Born, W
机构
[1] Univ Zurich, Klin Balgrist, Res Lab Calcium Metab, Dept Orthopaed Surg, CH-8006 Zurich, Switzerland
[2] Univ Zurich, Klin Balgrist, Res Lab Calcium Metab, Dept Med, CH-8006 Zurich, Switzerland
[3] Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland
关键词
calcitonin; calcitonin-gene-related peptide; receptor complex;
D O I
10.1042/0264-6021:3510347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor-activity-modifying proteins (RAMPs) with single transmembrane domains define the function of two G-protein-coupled receptors of the B family. Cell-surface complexes of human RAMP1 (hRAMP1) and human calcitonin (CT) receptor isotype 2 (hCTR2) or rat CT-receptor-like receptor (rCRLR) have now been identified through protein cross-linking, co-immunoprecipitation and confocal microscopy. They are two distinct CT-gene-related peptide (CGRP) receptors coupled to cAMP production and pharmacologically distinguished by the CT and CGRP antagonists salmon CT(8-32) and human or rat CGRP(8-37). Thus direct molecular interactions of hRAMP1 with hCTR2 or rCRLR are required for CGRP recognition, hCTR2, moreover, adopts non-traditional functions through its association with hRAMP1.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 16 条
[1]   A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1 [J].
Bühlmann, N ;
Leuthäuser, K ;
Muff, R ;
Fischer, JA ;
Born, W .
ENDOCRINOLOGY, 1999, 140 (06) :2883-2890
[2]   IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN [J].
CHANG, CP ;
PEARSE, RV ;
OCONNELL, S ;
ROSENFELD, MG .
NEURON, 1993, 11 (06) :1187-1195
[3]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[4]  
DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123
[5]   Tissue-specific mRNA expression of a calcitonin receptor-like receptor during fetal and postnatal development [J].
Fluhmann, B ;
Lauber, M ;
Lichtensteiger, W ;
Fischer, JA ;
Born, W .
BRAIN RESEARCH, 1997, 774 (1-2) :184-192
[6]   A HUMAN ORPHAN CALCITONIN RECEPTOR-LIKE STRUCTURE [J].
FLUHMANN, B ;
MUFF, R ;
HUNZIKER, W ;
FISCHER, JA ;
BORN, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (01) :341-347
[7]   The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor [J].
Fraser, NJ ;
Wise, A ;
Brown, J ;
McLatchie, LM ;
Main, MJ ;
Foord, SM .
MOLECULAR PHARMACOLOGY, 1999, 55 (06) :1054-1059
[8]   DISTINCT BINDING-SITES FOR CALCITONIN GENE-RELATED PEPTIDE AND SALMON-CALCITONIN IN RAT CENTRAL-NERVOUS-SYSTEM [J].
HENKE, H ;
TSCHOPP, FA ;
FISCHER, JA .
BRAIN RESEARCH, 1985, 360 (1-2) :165-171
[9]   Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function [J].
Husmann, K ;
Sexton, PM ;
Fischer, JA ;
Born, W .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 162 (1-2) :35-43
[10]  
KUESTNER RE, 1994, MOL PHARMACOL, V46, P246